Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of peretinoin (K-333) for prevention of hepatocellular carcinoma recurrence after curative treatment
jRCT2080222445Phase 3Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Mar 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in hepatocellular carcinoma (HCC) comparing Peretinoin arm with Placebo arm (2 arms). Started Mar 2014; status: completed.
02
Drugs
peretinoin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on jRCT2080222445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222445.